In Liu et al. (2022), affibodies targeting alpha-fetoprotein (AFP), a biomarker for liver cancer, were pre-assembled with β-sheet-forming peptides to create bioactive nanofibril aggregates [51]. Here, AFP is linked to liver cancer.